Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Backs EPCIS, Refines Advice As November 2023 DSCSA Deadline Approaches
Jul 06 2022
•
By
Bowman Cox
Further anti-counterfeiting refinements from the fda • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance